Saturday, August 2, 2025 8/2/2025

Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication

Award Number: R21AI104282
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2013
PERIOD OF PERFORMANCE END DATE: 01/31/2016

Group Awards By:

View Award Description

Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication - DESCRIPTION (provided by applicant): There are no methods currently available for the eradication of the latent reservoir in HIV-infected patients. The long-term goal of the proposed research is to develop a new method based on synthetic molecular sensors that is capable of targeting latently infected cells in HIV-infected patients for destruction. The objective of this particular application is to design constructs known as "Synthetic Molecular Sensors for HIV Eradication (SMaSHEd)" and determine their ability to eradicate latently infected cells from HIV-infected patients or from in vitro latency models. The central hypothesis is that the promoter regions from host genes and the binding sites for miRNAs whose expression can discriminate latently infected from uninfected cells can be used as sensors in SMaSHEd constructs to specifically express a suicide gene in latently infected cells. The rationale for the proposed research is that new methods for eradicating the latent reservoir are required that specifically target latently infected cells, and do not directly target the variable HIV provirus, require activation of HIV replication, or rely on the host immune system to eradicate activated cells. Guided by strong preliminary data, our hypothesis will be tested by pursuing the following specific aims: (1 & 2) Identify genes and miRNAs whose expression can discriminate latently infected primary CD4 T cells from uninfected cells, and (3) Determine the ability of SMaSHEd constructs to induce cell death in latently infected primary CD4 T cells. The analyses in Aim 1 & 2 will utilize RNA-Seq and smallRNA-Seq to identify the genes and miRNAs, respectively that are differentially expressed between latently infected and uninfected primary memory CD4 T cells derived from the in vitro model of our collaborator Dr. Vincente Planelles. Our final aim wil utilize procedures well established in the realm of synthetic biology to design SMaSHEd constructs containing the promoters and miRNA binding sites of genes (Aim 1) and miRNAs (Aim 2), respectively, that specifically sense the environment in latently infected cells. The abilty of these constructs to induce the expression of a suicide gene specifically in latently infected primary CD4 T cells will be assessed following transfection or transduction of mixtures of latently infected and uninfected cells from the in vitro primary CD4 T cell latency model of Dr. Planelles and of Dr. O'Doherty, as well as from HIV-infected patients. The research proposed in this application is innovative, in our opinion, because it will utilize the latest advances in synthetic biology and information gained from next generation sequencing platforms (i.e., RNA-Seq and smallRNA-Seq) to develop a novel method for eradicating latently infected cells. This will be significant because it is the first step in a continuum of research that is expected to lea to the development of a new strategy for the eradication of the latent reservoir in HIV-infected patients. Ultimately, SMaSHEd constructs will be developed for use with appropriate vectors (i.e., adeno-associated virus) for the treatment of HIV-infected patients, where, in contrast to gene therapy, they will only require transient expression to induce the destruction of latently infected cells.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2018 ( Subtotal = -$8,330 )
2018	2014	UNIVERSITY OF SOUTHAMPTON	UNIVERSITY RD	SOUTHAMPTON	HAMPSHIRE	SO17 1BJ		GBR	Allergy and Infectious Diseases Research	000	3	5/23/2018	NON-COMPETING CONTINUATION	-$8,330
														Subtotal = -$8,330

Issue Date FY: 2014 ( Subtotal = $148,500 )
2014	2014	UNIVERSITY OF SOUTHAMPTON	outhampton University Clinical and	Southampton				GBR	Allergy and Infectious Diseases Research	000	3	1/14/2014	NON-COMPETING CONTINUATION	$133,650
2014	2014	UNIVERSITY OF SOUTHAMPTON	outhampton University Clinical and	Southampton				GBR	Allergy and Infectious Diseases Research	001	3	6/6/2014	NON-COMPETING CONTINUATION	$14,850
														Subtotal = $148,500

Issue Date FY: 2013 ( Subtotal = $150,112 )
2013	2013	UNIVERSITY OF SOUTHAMPTON	outhampton University Clinical and	Southampton				GBR	Allergy and Infectious Diseases Research	002	2	7/25/2013	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$142,922
2013	2013	VETERANS MEDICAL RESEARCH FOUNDATION OF SAN DIEGO	3350 LA JOLLA VILLAGE DR 151A	SAN DIEGO	CA	92161	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	1	1/25/2013	NEW	$191,400
2013	2013	VETERANS MEDICAL RESEARCH FOUNDATION OF SAN DIEGO	3350 LA JOLLA VILLAGE DR 151A	SAN DIEGO	CA	92161	SAN DIEGO	USA	Allergy and Infectious Diseases Research	001	1	7/25/2013	NEW	-$184,210
														Subtotal = $150,112

Grand Total All Awards = $290,282

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication

Award Number: R21AI104282

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2013

PERIOD OF PERFORMANCE END DATE: 01/31/2016

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer